Literature DB >> 25301934

Role of B cells and antibodies in acquired immunity against Mycobacterium tuberculosis.

Jacqueline M Achkar1, John Chan2, Arturo Casadevall2.   

Abstract

Accumulating evidence has documented a role for B cells and antibodies (Abs) in the immunity against Mycobacterium tuberculosis (Mtb). Passive transfer studies with monoclonal antibodies (mAbs) against mycobacterial antigens have shown protection against the tubercle bacillus. B cells and Abs are believed to contribute to an enhanced immune response against Mtb by modulating various immunological components in the infected host including the T-cell compartment. Nevertheless, the extent and contribution of B cells and Abs to protection against Mtb remains uncertain. In this article we summarize the most relevant findings supporting the role of B cells and Abs in the defense against Mtb and discuss the potential mechanisms of protection.
Copyright © 2015 Cold Spring Harbor Laboratory Press; all rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25301934      PMCID: PMC4355258          DOI: 10.1101/cshperspect.a018432

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Med        ISSN: 2157-1422            Impact factor:   6.915


  153 in total

1.  Enhanced immunoprotective potential of Mycobacterium tuberculosis Ag85 complex protein based vaccine against airway Mycobacterium tuberculosis challenge following intranasal administration.

Authors:  Pramod K Giri; Indu Verma; Gopal K Khuller
Journal:  FEMS Immunol Med Microbiol       Date:  2006-07

Review 2.  The role of antibody-mediated immunity in defense against Mycobacterium tuberculosis: advances toward a novel vaccine strategy.

Authors:  Aharona Glatman-Freedman
Journal:  Tuberculosis (Edinb)       Date:  2006-04-03       Impact factor: 3.131

Review 3.  Overview of safety of non-biologic and biologic DMARDs.

Authors:  Eric M Ruderman
Journal:  Rheumatology (Oxford)       Date:  2012-12       Impact factor: 7.580

4.  B-lymphocytes and co-stimulatory molecules in Mycobacterium tuberculosis infection.

Authors:  M Corominas; V Cardona; L Gonzalez; J A Caylà; G Rufi; M Mestre; E Buendia
Journal:  Int J Tuberc Lung Dis       Date:  2004-01       Impact factor: 2.373

5.  CXCR5⁺ T helper cells mediate protective immunity against tuberculosis.

Authors:  Samantha R Slight; Javier Rangel-Moreno; Radha Gopal; Yinyao Lin; Beth A Fallert Junecko; Smriti Mehra; Moises Selman; Enrique Becerril-Villanueva; Javier Baquera-Heredia; Lenin Pavon; Deepak Kaushal; Todd A Reinhart; Troy D Randall; Shabaana A Khader
Journal:  J Clin Invest       Date:  2013-01-02       Impact factor: 14.808

6.  A mycobacterial lipoarabinomannan specific monoclonal antibody and its F(ab') fragment prolong survival of mice infected with Mycobacterium tuberculosis.

Authors:  B Hamasur; M Haile; A Pawlowski; U Schroder; G Kallenius; S B Svenson
Journal:  Clin Exp Immunol       Date:  2004-10       Impact factor: 4.330

7.  Induction of a protective response with an IgA monoclonal antibody against Mycobacterium tuberculosis 16kDa protein in a model of progressive pulmonary infection.

Authors:  Yamilé López; Daniel Yero; Gustavo Falero-Diaz; Nesty Olivares; María E Sarmiento; Sergio Sifontes; Rosa L Solis; Jorge A Barrios; Diana Aguilar; Rogelio Hernández-Pando; Armando Acosta
Journal:  Int J Med Microbiol       Date:  2009-01-20       Impact factor: 3.473

8.  Location of intra- and extracellular M. tuberculosis populations in lungs of mice and guinea pigs during disease progression and after drug treatment.

Authors:  Donald R Hoff; Gavin J Ryan; Emily R Driver; Cornelius C Ssemakulu; Mary A De Groote; Randall J Basaraba; Anne J Lenaerts
Journal:  PLoS One       Date:  2011-03-21       Impact factor: 3.240

9.  IgE mediates killing of intracellular Toxoplasma gondii by human macrophages through CD23-dependent, interleukin-10 sensitive pathway.

Authors:  Ioannis Vouldoukis; Dominique Mazier; Daniel Moynet; Denis Thiolat; Denis Malvy; M Djavad Mossalayi
Journal:  PLoS One       Date:  2011-04-22       Impact factor: 3.240

Review 10.  Monoclonal antibody-based therapies for microbial diseases.

Authors:  Carolyn Saylor; Ekaterina Dadachova; Arturo Casadevall
Journal:  Vaccine       Date:  2009-12-30       Impact factor: 3.641

View more
  12 in total

Review 1.  B cells and antibodies in the defense against Mycobacterium tuberculosis infection.

Authors:  Jacqueline M Achkar; John Chan; Arturo Casadevall
Journal:  Immunol Rev       Date:  2015-03       Impact factor: 12.988

Review 2.  B in TB: B Cells as Mediators of Clinically Relevant Immune Responses in Tuberculosis.

Authors:  Martin Rao; Davide Valentini; Thomas Poiret; Ernest Dodoo; Shreemanta Parida; Alimuddin Zumla; Susanna Brighenti; Markus Maeurer
Journal:  Clin Infect Dis       Date:  2015-10-15       Impact factor: 9.079

3.  The Functional Response of B Cells to Antigenic Stimulation: A Preliminary Report of Latent Tuberculosis.

Authors:  Willem J du Plessis; Léanie Kleynhans; Nelita du Plessis; Kim Stanley; Stephanus T Malherbe; Elizna Maasdorp; Katharina Ronacher; Novel N Chegou; Gerhard Walzl; Andre G Loxton
Journal:  PLoS One       Date:  2016-04-06       Impact factor: 3.240

4.  Tuberculosis vaccine development: Shifting focus amid increasing development challenges.

Authors:  A J Graves; D A Hokey
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

Review 5.  Antibodies and tuberculosis.

Authors:  Ashley J Jacobs; Juthathip Mongkolsapaya; Gavin R Screaton; Helen McShane; Robert J Wilkinson
Journal:  Tuberculosis (Edinb)       Date:  2016-08-26       Impact factor: 3.131

6.  Deregulated lncRNAs in B Cells from Patients with Active Tuberculosis.

Authors:  Yurong Fu; Xianqin Xu; Junfang Xue; Wenping Duan; Zhengjun Yi
Journal:  PLoS One       Date:  2017-01-26       Impact factor: 3.240

7.  Association of Immune Factors with Drug-Resistant Tuberculosis: A Case-Control Study.

Authors:  En-Tao Sun; Dan Xia; Ben-He Li; Jun Ma; Yuan-Yuan Dong; Shu-Shu Ding; Bai-Feng Chen; Yu-Feng Wen
Journal:  Med Sci Monit       Date:  2017-11-09

8.  Characterization of the Antigenic Heterogeneity of Lipoarabinomannan, the Major Surface Glycolipid of Mycobacterium tuberculosis, and Complexity of Antibody Specificities toward This Antigen.

Authors:  Alok Choudhary; Deendayal Patel; William Honnen; Zhong Lai; Raja Sekhar Prattipati; Ruixiang Blake Zheng; Ying-Chao Hsueh; Maria Laura Gennaro; Alfred Lardizabal; Blanca I Restrepo; Moncerrato Garcia-Viveros; Maju Joe; Yu Bai; Ke Shen; Kamar Sahloul; John S Spencer; Delphi Chatterjee; Tobias Broger; Todd L Lowary; Abraham Pinter
Journal:  J Immunol       Date:  2018-04-02       Impact factor: 5.422

9.  Elevation in the counts of IL-35-producing B cells infiltrating into lung tissue in mycobacterial infection is associated with the downregulation of Th1/Th17 and upregulation of Foxp3+Treg.

Authors:  Chen Chen; Huan Xu; Ying Peng; Hong Luo; Gui-Xian Huang; Xian-Jin Wu; You-Chao Dai; Hou-Long Luo; Jun-Ai Zhang; Bi-Ying Zheng; Xiang-Ning Zhang; Zheng W Chen; Jun-Fa Xu
Journal:  Sci Rep       Date:  2020-08-06       Impact factor: 4.379

Review 10.  Immunological Impacts of Diabetes on the Susceptibility of Mycobacterium tuberculosis.

Authors:  Birhanu Ayelign; Markos Negash; Meaza Genetu; Tadelo Wondmagegn; Tewodros Shibabaw
Journal:  J Immunol Res       Date:  2019-09-09       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.